XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles OPCH Q1 2026 Earnings EPS Beat Fails to Lift Stock Revenue Picture Unclear Crypto Industry Faces Growing Quantum Computing Risk as Threat to Blockchain Security Becomes Credible Concentrix Corporation CNXC Q1 2026 Earnings EPS Miss Despite Slight Revenue Growth Stock Rises BLFY Q3 2025 Earnings Narrower Loss Than Expected but Negative Surprise Genius Group Limited GNS Q4 2022 Earnings Massive EPS Miss Overshadows Quarter